WO2003011891A1 - A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes - Google Patents
A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes Download PDFInfo
- Publication number
- WO2003011891A1 WO2003011891A1 PCT/IN2001/000142 IN0100142W WO03011891A1 WO 2003011891 A1 WO2003011891 A1 WO 2003011891A1 IN 0100142 W IN0100142 W IN 0100142W WO 03011891 A1 WO03011891 A1 WO 03011891A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- betulinic acid
- acid
- extracting
- isolation
- rhizomes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Definitions
- the present invention relates to a process for the isolation of betulinic acid. More particularly, the present invention relates to a process for the isolation of betulinic acid from Nelumbo n ⁇ cifera Gaertn. (Family Nymphaeaceae). The acid thus obtained has potent therapeutic activity and is useful as anti-HIV, anti-tumoral and melanoma specific cytotoxic agent. Background of the invention
- Nelumbo nucifera Gaertn. (Family Nymphaeaceae) is a large aquatic herb with slender elongate, branched creeping stems and stout creeping yellowish white coloured rhizomes.
- the flower of Nelumbo nucifera Gaertn. is the national flower of India. Almost all parts of this plant are used in Indian Traditional Medicine to cure several diseases [Chopra, R. N., Chopra I. C, and Handa, K. L. (1958), Extra Drugs of India, 2 nd ed., U. N. Dhur & Sons Pvt. Ltd., Calcutta, p. 679; Kirtikar, K. R, and Basu, B.
- Betulinic acid has been isolated and identified from several plant species.
- the hexane extract of Picramnia pentandra showed the presence of 3 - epi-betulinic acid [Herz, W., Santhanam, P. S., and Wahlberg, I., (1972), Phytochemistry, Vol. 11, pp. 3061 - 3063].
- the plants Lemaireocereus stellatus, L. pruinosus, Machaereocereus eruca have been found to contain oleanolic acid, betulinic acid and machaeric acid (21 - keto-oleanolic acid) [Djerassi, C, Liu, L. H., Farkar, E., Lippman, A.
- Oleanolic acid, betulin, betulinic acid, erythrodiol, maniladiol and several other triterpenes have been isolated from cactus species along with some other cactus triterpenes such as longispinogenin, gummosogenin and cochalic acid, all belonging to the Cactaceae family.
- Oleanolic acid and betulinic acid have also been isolated from several plants of the Lemaireocereus specie such as Lemaireocereus quovedonis, L. griseus, L. hystrix, L. treleasei.
- petriel and A. whitei and of the wood, bark and leaves of A. macrocarpa are reported to possess triterpenes like betulinic acid, ceanothic acid and alphitolic acid [Branch, G. B., Buragers, D. V., Dunstan, P. J., Foo, L. Y., Green, G. H., Mack, J. P. G., Ritchie, E, and Taylor, W. C, (1972), Aust. J. Chem., Vol. 25, pp. 2209 - 2216].
- the bark of Akania luceus (commonly known as 'turnip wood') has been found to contain betulinic acid, betulonic acid and 3— desoxy betulonic acid [Krajniak, E., Ritchie, E., and Taylor, W. C, (1969), Aust. J. Chem., Vol. 22, ppl331 - 1332].
- the trunk wood of Caraipa grandifolia Mart (Family - Guttiferae) contains sitosterol, lupeol, lupenone, betulinic acid and vanillin.
- densiflora Mart contains sitosterol, lupeol, friedelin, betulinic acid and vanillin [Alves De Lima, R., and Gottlieb, O. R., (1972), Phytochemistry, Vol. 11, pp. 2307 - 2309].
- Betulinic acid and ursolic acid have been isolated from Hedyotis chrystoricha (Palib) Merr [Fang, Z., Yang, Y., and Zhou, G., (1992), Merr. Chug. Kuo Chung Y o Tsa Chih, Vol. 17(2), pp. 98 - 100].
- Betulinic acid a steroidal triterpenoid has been found to possess several pharmacological properties.
- the cytotoxic activity of betulimc acid and other ellagic acid derivatives from Agrostistachys hookery has been reported [Choi, Y. N., Pezzuto, J. M., Kinghorn, A. D., and Farnsworth, N. R., (1988), Planta Medica, Vol. 54(6), pp. 511 - 513].
- Topical application of l ⁇ g of 12 - O - tetradecanoyl phorbol -.13 - acetate (TPA) to the ears of mice was shown to induce oedema and this TPA induced inflammation was inhibited by 4 - methyl sterol and triterpene derivatives.
- the inhibitory effects of sterol and triterpene derivatives including betulinic acid on TPA - induced inflammation roughly paralleled their inhibitory activities against tumor promotion [Yasukawa, K., Takidom, M., Matsu oto, T., Takeuchi, M., Nakagawa, S., (1991), Oncology, Vol. 48(1), pp. 72 - 76].
- Betulinic acid and platonic acid isolated from the leaves Syzigium calviforum were found to be inhibitors of HIV replication in H9 lymphocyte cells. Evaluation of anti-HTV activity with eight derivatives of betulinic acid revealed that dihydro-betulinic acid was also a potent inhibitor of HTV replication; the C-3 hydroxy group of C-17 carboxylic acid group, as well as the C-19 substituents, contribute to enhance the anti-HTV activity [Fujioka, T., Kashiwada, Y., Lee, K. H, (1994), J. Natural Product, Vol. 57(2), pp. 243 - 247].
- HTV - 1 human immunodeficiency virus type 1
- Plant constituents such as taxol, camptothecin, podophyllotoxin, vinblastine and vincristine represent some of the most important drugs currently used for the treatment of human cancers. They are structurally complex and capable of facilitating unique mechanisms of cytotoxicity like necrosis or apoptosis. These lead compounds have been used as models for development of anti-cancer chemotherapeutic drugs.
- Betulinic acid isolated from the stem bark of Ziziphus mauritiana Lam., (Rhamnaceae) (white birch trees) has been found to be active as a selective inhibitor of human melanoma which acts by induction of apoptosis as a melanoma specific cytotoxic agent [Pisha, E., Chai, H., Lee, I.S., Chagentréea, T. E., Farnsworth, N. R., Cordell, G. A, Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., Wani, M. C, Wall, M. E., Hieken, T. J., Dasgupta, T. K., and Pezzuto, J. M., (1995), Nature Medicine, Vol. 1(10), pp. 1046 - 1051].
- the main object of the invention is to provide a process for the isolation of betulinic acid useful as anti-HTV, anti-tumoral and melanoma specific cytotoxic agent.
- nucifera such as leaves, stalks, flowers and seeds were subjected to phyt ' ochemical methods for the isolation of betulinic acid with little success. It was noted that the rhizome showed the presence of substantial amounts of betulinic acid.
- the present invention provides a process for the isolation of betulinic acid which comprises extracting rhizomes of Nelumbo nucifera Gaertn (Family - Nymphaeaceae) with a polar solvent at a temperature in the range of 50 - 60°C by conventional soxhlet extraction methods, concentrating the extracts at a pressure in the range of 30 - 50 mm Hg, adding water to the above said concentrate residue, extracting the said residue successively with non-polar solvents, extracting the aqueous phase with organic solvent, concentrating the above obtained organic solvent phase and purifying the product by conventional methods such as column chromatography followed by crystallization to give pure betulinic acid.
- the polar solvents used for extraction are selected from the group consisting of methanol, ethanol, butanol, propanol, dimethyl formamide and dimethyl sulphoxide.
- the non-polar solvent used is selected from petroleum ether (b.p. 40 - 60°C), petroleum ether (b.p. 60 - 80°C), carbon tetrachloride, heptane and benzene.
- the organic solvent used for the final extraction are selected from the group consisting of chloroform, methanol and any mixture thereof.
- the rhizomes fo the plant N. nucifera Gaertn were collected form Sandhipur, Midnapore district of West Bengal, India. Taxonomic identification of the plant was performed by Dr. D. C. S, Raju of Botanical Survey of India, Shibpur, Howrah. A voucher specimen (N-21) is being maintained in the laboratory for future reference.
- the rhizomes were sliced into small pieces, dried, pulverized by a mechanical grinder, passed through a 40 mesh sieve and stored in a well closed container for extraction. Extraction and isolation;
- the dried powder rhizome of the plant was extracted with methanol in a soxhlet extractor. After evaporation of the solvent from the extract, a brown coloured dry mass was obtained which was taken in a small amount of water and extracted successively with petroleum ether (b.p. 60 - 80°C) and benzene.
- the aqueous phase of the benzene extract was acidified using 2M sulphuric acid upto pH 5 - 5.5 and extracted with chloroform. This was concentrated under vacuum to dryness and subjected to chromatographic separation of silica gel (60 - 120 mesh) column (20 x 5.5 cm).
- the dried powdered rhizomes was again extracted with ethyl alcohol (95 % v/v) and same procedure was adopted. The amount of betulinic acid obtained was relatively less.
- the dried powdered rhizomes was also extracted with petroleum ether (b.p. 40 - 60°C and 60 - 80°C), benzene, n-hexane, propanol, butanol, separately concentrated under reduced pressure and the concentrated mass was subjected to column chromatographic separation as described above. Pentacyclic triterpene like betulinic acid was not separated by these methods.
- the NMR spectrum showed a 15 proton multiplet ranging from ⁇ 8.77 - 9.16 which accounts for five methyl groups.
- the methyl group of the isopropenyl function resonates as a triplet centered at ⁇ 8.18 and the proton on the hydroxyl bearing carbon resonates as a triplet centered at ⁇ 6.53 suggesting that this carbon is adjacent to a single methylene group.
- Mass spectrum of the isolated substance showed principal peaks at m/z 456 (M), 438 (m - 18), 423 (M-33), 406 (M-50) and the peaks in the mass range of 190 - 250 were m/z 248, 220, 219, 207, 203 and 1S9. [ ] 23 + 7.9° (c.
- betulinic acid as provided above as formula I, it is clear that betulinic acid, the therapeutically active pentacyclic triterpenoid embodying the invention is shown by way of illustration only and not as a limitation of the invention.
- the principal features of the invention may be employed in respect of various other plant species for isolation of the pentacyclic triterpene betulinic acid without departing from the scope of the invention.
- Rhizomes were collected, dried under shade, pulverized by mechanical grinder and passed through a 40 mesh sieve.
- Powdered rhizomes were extracted with methanol (b.p. 65°C) in a soxhlet extractor for successive 48 hours with constant supply of heat (temperature 60 - 65°C) by a heating mantle.
- the aqueous phase (pH 5.5 - 6) was further extracted with chloroform.
- This extract was subjected to column chromatographic separation over silica gel (60 - 120 mesh) column and eluted with a solvent system comprising chloroform:methanol (1:1).
- Crystalline precipitate separated out which was filtered through Whatman filter paper No. 1, and dried in air.
- the product was recrystallised from methanol by treating with activated charcoal.
- the white needle shaped crystalline material was characterized by studying its different physico-chemical characteristics such as melting point, UV, IR, NMR, mass spectral characteristics and compared with values reported in the art and with an authenticated sample of betulinic acid. The data showed the compound to be betulinic acid.
- Example 1 is illustrative and should not be construed to limit the scope of the invention.
- the recrystallised material was found to be a white needle shaped crystalline material which when subjected to study of characteristics such as UV, TR, NMR, mass spectra characteristics and compared with values for an authenticated sample of betulinic acid was identified as betulinic acid (C30H48O3). 1000 gm of powdered rhizome yielded 6.25 gm of isolated crystalline betulinic acid.
- the process of the present invention provides a therapeutically effective pentacyclic triterpene betulinic acid in good yield (0.53 - 0.60 % w/w with respect to dry powdered rhizomes).
- This compound is reported to have potent anti-HTV, anti-tumoral and human melanoma specific cytotoxic acitivity.
- a pentacyclic triterpenoid betulinic acid is isolated from a commonly occurring plant N. nucifera Gaertn (Family - Nymphaeaceae).
- the process of the invention provides a good yield and is economical.
- the process of the invention is useful for the isolation of compounds similar to betulinic acid from the vast resources of medicinal plants in India.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2001/000142 WO2003011891A1 (en) | 2001-08-03 | 2001-08-03 | A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2001/000142 WO2003011891A1 (en) | 2001-08-03 | 2001-08-03 | A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003011891A1 true WO2003011891A1 (en) | 2003-02-13 |
Family
ID=11076371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2001/000142 WO2003011891A1 (en) | 2001-08-03 | 2001-08-03 | A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2003011891A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011064710A1 (en) | 2009-11-30 | 2011-06-03 | University Of Kwazulu-Natal | In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives |
WO2013160881A1 (en) | 2012-04-26 | 2013-10-31 | Universidade De Aveiro | Method for obtaining an extract rich in triterpenic acids from eucalyptus barks |
CN112521441A (en) * | 2020-12-29 | 2021-03-19 | 江西省科学院应用化学研究所 | Method for separating and purifying betulinic acid from lotus seedpod shells |
-
2001
- 2001-08-03 WO PCT/IN2001/000142 patent/WO2003011891A1/en active Application Filing
Non-Patent Citations (1)
Title |
---|
MUKHERJEE, PULOK K. ET AL: "Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera", PLANTA MED. (1997), 63(4), 367-369, XP008001367 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011064710A1 (en) | 2009-11-30 | 2011-06-03 | University Of Kwazulu-Natal | In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives |
US8685469B2 (en) | 2009-11-30 | 2014-04-01 | University Of Kwazulu-Natal | In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives |
WO2013160881A1 (en) | 2012-04-26 | 2013-10-31 | Universidade De Aveiro | Method for obtaining an extract rich in triterpenic acids from eucalyptus barks |
CN112521441A (en) * | 2020-12-29 | 2021-03-19 | 江西省科学院应用化学研究所 | Method for separating and purifying betulinic acid from lotus seedpod shells |
CN112521441B (en) * | 2020-12-29 | 2021-09-28 | 江西省科学院应用化学研究所 | Method for separating and purifying betulinic acid from lotus seedpod shells |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mukherjee et al. | Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera | |
Patocka | Biologically active pentacyclic triterpenes and their current medicine signification | |
Tijjani et al. | Isolation and characterization of lup-20 (29)-ene-3, 28-diol (Betulin) from the stem-bark of Adenium obesum (Apocynaceae) | |
Aguirre et al. | Topical anti-inflammatory activity of 2α-hydroxy pentacyclic triterpene acids from the leaves of Ugni molinae | |
Wadouachi et al. | Triterpenes and steroids from the stem bark of Gambeya boiviniana Pierre | |
Aziz | Studies on the chemical constituents of Thymus serpyllum | |
Suresh et al. | Phytochemical potential of Annona reticulata roots for antiproliferative activity on human cancer cell lines | |
El Deeb et al. | Phytochemical and pharmacological studies of Maytenus forsskaoliana | |
De Felice et al. | New polyhydroxylated triterpenes and anti-inflammatory activity of Salvia hierosolymitana | |
Sharma et al. | A new aliphatic acid from Achyranthes aspera Linn. roots | |
Mallavadhani et al. | Diospyros melanoxylon leaves: a rich source of pentacyclic triterpenes | |
WO2003011891A1 (en) | A process for the isolation of betulinic acid from nelumbo nucifera gaertn rhizomes | |
Pérez Gutiérrez | Anti-inflammatory effect of birsonimadiol from seeds of Byrsonima crassifolia | |
Sawale et al. | Antioxidant properties of cycloartenol isolated from Euphorbia neriifolia leaves | |
Ageta et al. | Chemotaxonomy of ferns, 3. Triterpenoids from Polypodium polypodioides | |
Akhtar et al. | Pentacyclic triterpenes from the stem bark of Mimusops elengi L. | |
Bhat et al. | Isolation & characterisation of beta-sitosterol from the rhizomes of Arisaema utile and its evaluation for antioxidant activity | |
Khedr et al. | Phytochemical and biological screening of the leaves of Ficus pandurata Hance. Cultivated in Egypt | |
Ahmed et al. | Triterpenoid antioxidant agents found in Holoptelea integrifolia (Roxb) Planch | |
Sultana et al. | Phytochemical studies on Alstonia scholaris | |
Rao et al. | Chemical examination and biological studies on the bark of Crataeva nurvala Buch.-Ham. | |
Migas et al. | Isoprene derivatives from the leaves and callus cultures of Vaccinium corymbosum var. bluecrop | |
Dutta et al. | Chemical constituents from Sarcostemma acidum (Roxb.) Voigt | |
Ngadjui et al. | Thomandertriol, a triterpenoid from the twigs of Thomandersia laurifolia | |
Ali | Lupene Triterpenoids from the Stem Bark of Albizia lebbeck, Leaves of Leptospermum scoparium and Roots of Nardostachys jatamansi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EE ES FI GB GD GE GH GM HU ID IL IN IS JP KE KG KP KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ PL PT RO RU SD SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZW AM AZ BY KG KZ MD TJ TM AT BE CH CY DE DK ES FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |